Pediatrix Medical Group
MD· Services· Fiscal year ends in December
Mark S. Ordan is the CEO of Pediatrix Medical Group.
Executives5
See all- 1Mary Ann E. MooreExecutive Vice President, General Counsel, Chief Administrative Officer and SecretaryFY2023
- 2James D. Swift, M.D.Former Chief Executive OfficerFY2022
- 3Don Gregory NeebExecutive Vice President, Chief Investment & Strategy OfficerNot disclosed
- 4Kasandra H. RossiExecutive Vice President, Chief Financial Officer & TreasurerNot disclosed
- 5Mark S. OrdanChief Executive OfficerNot disclosed
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allPediatrix Medical Group paid its 2 named executives $3.2M in total in FY2023 (Dec).
| Name | |||
|---|---|---|---|
| Mary Ann E. MooreExecutive Vice President, General Counsel, Chief Administrative Officer and Secretary | |||
| James D. Swift, M.D.Former Chief Executive Officer | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers14
See all
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board2
See all- John M. Starcher, Jr.Director · 5 yr on the boardIndependentStrategy—Paid as an executive
- Sylvia J. YoungDirector · 2 yr on the boardIndependentAudit—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Mar 27, 2026 | FY2025 |
| Annual report | 10-K | Feb 19, 2026 | FY2025 |
| Proxy statement | DEF 14A | Mar 28, 2025 | FY2024 |
| Annual report | 10-K | Feb 20, 2025 | FY2024 |
| Proxy statement | DEF 14A | Mar 28, 2024 | FY2023 |
| Annual report | 10-K | Feb 20, 2024 | FY2023 |
